Albert Bourla, Pfizer CEO (Leigh Vogel/Getty Images for Concordia Summit)

Up­dat­ed: Pfiz­er's ac­tivist says board must 'hold man­age­ment ac­count­able' for R&D short­com­ings

Ac­tivist in­vestor Star­board Val­ue said Pfiz­er’s ex­ec­u­tives haven’t de­liv­ered on what they once called one of the best pipelines in the in­dus­try, and need to …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.